Bain Capital Public Equity Management II’s Novartis NVS Stock Holding History

Bain Capital Public Equity Management II’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-440,233	Closed	-$36.3M	–	51
2020 Q1	$36.3M	Sell	440,233 -268,058	-38%	-$23.9M	4.25%	11
2019 Q4	$67.1M	Buy	708,291 +426,731	+152%	+$38.3M	6.36%	4
2019 Q3	$24.5M	Sell	281,560 -703,194	-71%	-$63.1M	2.32%	13
2019 Q2	$89.9M	Buy	+984,754	New	+$83.3M	8.3%	3

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bain Capital Public Equity Management II's NVS Position: Q2 2020 in Review

Bain Capital Public Equity Management II sold out of Novartis (NVS) in Q2 2020, closing a stake of 440,233 shares — an estimated $36.3M sold.

Bain Capital Public Equity Management II first reported a position in NVS in Q2 2019 and held it in 4 quarters. The position peaked at $89.9M in Q2 2019. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Bain Capital Public Equity Management II reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Bain Capital Public Equity Management II sold 440,233 Novartis shares in Q2 2020, an estimated $36.3M.
Bain Capital Public Equity Management II first reported a position in Novartis in Q2 2019 and held it in 4 quarters.
Bain Capital Public Equity Management II's Novartis position peaked at $89.9M in Q2 2019.
1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Bain Capital Public Equity Management II's 13F filing for Q2 2020, filed 14 Aug 2020.